Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis

BACKGROUND: Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversible, dose-dependent side effects, less frequent but potentially severe, systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Quallich, Leonard G, Greenson, Joel, Haftel, Hilary M, Fontana, Robert J
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2001
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56591/
https://www.ncbi.nlm.nih.gov/pubmed/11570976
http://dx.doi.org/10.1186/1471-230X-1-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC56591/
https://www.ncbi.nlm.nih.gov/pubmed/11570976
http://dx.doi.org/10.1186/1471-230X-1-8

Ejemplares similares